24 July 2012 - Alethia Biotherapeutics Inc, a privately held pre-clinical stage biotechnology company, announced yesterday that it has received a notice of allowance in the United States for a 'composition of matter' patent entitled, 'Polynucleotides and Polypeptide Sequences involved...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up